2018
Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation
Olliaro P, Grogl M, Boni M, Carvalho E, Chebli H, Cisse M, Diro E, Cota G, Erber A, Gadisa E, Handjani F, Khamesipour A, Llanos-Cuentas A, Carvajal L, Grout L, Lmimouni B, Mokni M, Nahzat M, Salah A, Ozbel Y, Pascale J, Molina N, Rode J, Romero G, Ruiz-Postigo J, Saravia N, Soto J, Uzun S, Mashayekhi V, Vélez I, Vogt F, Zerpa O, Arana B. Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation. PLOS Neglected Tropical Diseases 2018, 12: e0006141. PMID: 29329311, PMCID: PMC5785032, DOI: 10.1371/journal.pntd.0006141.Peer-Reviewed Original ResearchConceptsCutaneous leishmaniasisTrial methodologyNew World cutaneous leishmaniasisLocalized Cutaneous LeishmaniasisCurrent treatment recommendationsClinical trial methodologyFuture clinical researchFuture trialsTreatment recommendationsClinical evaluationOutcome measuresCandidate treatmentSystematic reviewClinical sitesClinical researchStandardized assessmentTreatment effectsLeishmaniasisTrialsTreatmentInconsistent methodologyLevel of consensusWeak evidenceSeparate meetingsGuidance paper
2015
A Meta-analytic Review of Non-specific Effects in Randomized Controlled Trials of Cognitive Remediation for Schizophrenia
Radhakrishnan R, Kiluk BD, Tsai J. A Meta-analytic Review of Non-specific Effects in Randomized Controlled Trials of Cognitive Remediation for Schizophrenia. Psychiatric Quarterly 2015, 87: 57-62. PMID: 25952944, PMCID: PMC4637248, DOI: 10.1007/s11126-015-9362-6.Peer-Reviewed Original ResearchConceptsCognitive remediationCognitive test performancePre-post changesCognitive performanceTest performanceControl groupCR trialsEffect size changesDuration of illnessRandomized Controlled TrialsDuration of treatmentNon-specific effectsControlled TrialsPsychiatric symptomsTrial methodologyParticipant ageAnalytic reviewTrial durationStudy characteristicsSchizophreniaSample sizeTrialsRCTsDurationAge
2009
Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity
Mongiu A, McVary K. Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity. Current Prostate Reports 2009, 7: 63-69. DOI: 10.1007/s11918-009-0010-1.Peer-Reviewed Original ResearchLower urinary tract symptomsBenign prostatic hyperplasiaBPH/lower urinary tract symptomsUrinary tract symptomsLifestyle modificationTract symptomsProstatic hyperplasiaGlobal public health challengeParticular polymorphismsCommon neoplastic conditionPrevalence of obesityClinical trial methodologyPublic health challengeStrong independent relationshipProstate sizePhysical inactivityTrial methodologyNeoplastic conditionsEpidemiological studiesObesityHealth challengesIndependent relationshipIndividual treatmentHyperplasiaSymptomsLower urinary tract symptoms, benign prostatic hyperplasia, and obesity
Mongiu AK, McVary KT. Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity. Current Urology Reports 2009, 10: 247-253. PMID: 19570484, DOI: 10.1007/s11934-009-0041-8.Peer-Reviewed Original ResearchConceptsLower urinary tract symptomsBenign prostatic hyperplasiaBPH/lower urinary tract symptomsUrinary tract symptomsLifestyle modificationTract symptomsProstatic hyperplasiaGlobal public health challengeParticular polymorphismsCommon neoplastic conditionPrevalence of obesityClinical trial methodologyPublic health challengeStrong independent relationshipProstate sizePhysical inactivityTrial methodologyNeoplastic conditionsEpidemiological studiesObesityHealth challengesIndependent relationshipIndividual treatmentHyperplasiaSymptoms
2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology
Schneider L, Tariot P, Lyketsos C, Dagerman K, Davis K, Davis S, Hsiao J, Jeste D, Katz I, Olin J, Pollock B, Rabins P, Rosenheck R, Small G, Lebowitz B, Lieberman J. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology. American Journal Of Geriatric Psychiatry 2001, 9: 346-360. PMID: 11739062, DOI: 10.1097/00019442-200111000-00004.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply